First Time Loading...
G

Genedrive PLC
LSE:GDR

Watchlist Manager
Genedrive PLC
LSE:GDR
Watchlist
Price: 3.375 GBX 3.85%
Updated: Mar 29, 2024

Intrinsic Value

GDR's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Genedrive Plc is a holding company, which engages in the development of drugs and disease diagnostics. [ Read More ]

The intrinsic value of one GDR stock under the Base Case scenario is 0.209 GBX. Compared to the current market price of 3.375 GBX, Genedrive PLC is Overvalued by 94%.

Key Points:
GDR Intrinsic Value
Base Case
0.209 GBX
Overvaluation 94%
Intrinsic Value
Price
G
Worst Case
Base Case
Best Case

Valuation Backtest
Genedrive PLC

Backtest GDR Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling GDR stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of Genedrive PLC's business.

What risks and challenges
does Genedrive PLC face in the near future?

Summarize the latest earnings report
of Genedrive PLC.

Provide P/E
for Genedrive PLC and its competitors.

Financials

Balance Sheet Decomposition
Genedrive PLC

Current Assets 4.1m
Cash & Short-Term Investments 2.6m
Receivables 989k
Other Current Assets 525k
Non-Current Assets 392k
PP&E 392k
Current Liabilities 2.4m
Accounts Payable 935k
Other Current Liabilities 1.5m
Non-Current Liabilities 19k
Long-Term Debt 19k
Efficiency

Earnings Waterfall
Genedrive PLC

Revenue
55k GBP
Operating Expenses
-5.3m GBP
Operating Income
-5.2m GBP
Other Expenses
74k GBP
Net Income
-5.2m GBP

Free Cash Flow Analysis
Genedrive PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

GDR Profitability Score
Profitability Due Diligence

Genedrive PLC's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

29/100
Profitability
Score

Genedrive PLC's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

GDR Solvency Score
Solvency Due Diligence

Genedrive PLC's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
57/100
Solvency
Score

Genedrive PLC's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GDR Price Targets Summary
Genedrive PLC

There are no price targets for GDR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

GDR Price
Genedrive PLC

1M 1M
-33%
6M 6M
-67%
1Y 1Y
-91%
3Y 3Y
-95%
5Y 5Y
-85%
10Y 10Y
-99%
Annual Price Range
3.375
52w Low
3.125
52w High
36.75
Price Metrics
Average Annual Return 5.98%
Standard Deviation of Annual Returns 78.08%
Max Drawdown -99%
Shares Statistics
Market Capitalization 4.5m GBX
Shares Outstanding 134 351 008
Percentage of Shares Shorted
N/A

GDR Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Genedrive PLC

Country

United Kingdom

Industry

Life Sciences Tools & Services

Market Cap

4.5m GBP

Dividend Yield

0%

Description

Genedrive Plc is a holding company, which engages in the development of drugs and disease diagnostics. The Company’s Genedrive device is a molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Company’s commercial products include Genedrive MT-RNR1, Genedrive BioPlex, Genedrive HCV ID Kit and Genedrive 96 SARS-CoV-2 Ki. Genedrive MT-RNR1 is a commercial test for antibiotic induced hearing loss. Genedrive BioPlex is developed for the determination of military biothreats from pathogens. Genedrive HCV ID Kit is effective in the diagnosis of Hepatitis C Virus (HCV) infection in resource limited settings. Genedrive 96 SARS-CoV-2 Ki is a plate format of a COVID-19 molecular test for high throughput use, which detects all known variants of COVID-19.

Contact

MANCHESTER
48 Grafton Street
+441619890245.0
http://www.genedriveplc.com/

IPO

2007-04-04

Employees

46

Officers

CFO, Secretary & Director
Mr. Russell John Shaw
CEO & Director
Mr. James Cheek
Chief Scientific Officer & Executive Director
Dr. Gino Miele

See Also

Discover More
What is the Intrinsic Value of one GDR stock?

The intrinsic value of one GDR stock under the Base Case scenario is 0.209 GBX.

Is GDR stock undervalued or overvalued?

Compared to the current market price of 3.375 GBX, Genedrive PLC is Overvalued by 94%.